SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems Inc., a development stage, venture-backed medical device company, completed Series C financing of $35M on June 12, 2008. EBR Systems is developing a novel technology, the first leadless pacing system for cardiac stimulation applications.
The financing was led by Delphi Ventures, with participation by all current investors, SV Life Science Advisers, Split Rock Partners, Frazier Healthcare Ventures, and De Novo Ventures.
The Series C funding will be used to complete product development and to initiate clinical trials of an implantable pacing device for left ventricular stimulation for the treatment of Heart Failure.
Contacts
EBR Systems, Inc. Rick Riley, CEO, 408-720-1906 ext. 222
